Heymach, J. V., Yamamoto, N., Girard, N., Ruiter, G., Smit, E. F., Planchard, D., Nadal, E., Wu, Y., Zugazagoitia, J., Tu, H., Baik, C. S., Yoh, K., Soo, R. A., Zhao, Y., Sabari, J. K., Wermke, M., Scheffler, M., Ahn, M., Fernamberg, K., Schroeter, L., Sadrolhefazi, B., Thamer, C., Eigenbrod-Giese, S., Popat, S. (2026). First-Line Zongertinib in Advanced
                    <i>HER2</i>
                    -Mutant Non–Small-Cell Lung Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2516969